U.S. Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants), By Workflow (Upstream, Fermentation, Downstream), By End Use, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within Immediate
U.S. Single-use Bioprocessing Market Trends
The U.S. single-use bioprocessing market size was estimated at USD 9.34 billion in 2024 and is projected tgrow at a CAGR of 15.04% from 2025 t2030. Due tthe high demand for biopharmaceuticals, suppliers have made their disposable product offerings more robust and inclusive. Single-use equipment suppliers are trying tfulfill end users' growing and ever-changing expectations. Furthermore, significant technological advancements in bioreactor designs, mixing systems, fluid assemblies, and liner technologies are anticipated tdrive the implementation of single-use technology for biopharmaceutical developments & advancements.
The U.S. single-use bioprocessing industry experienced a positive impact from the COVID-19 pandemic, particularly due tthe increased demand for single-use products driven by the heightened need for vaccines, treatments, and assays. These products played an important role in facilitating the rapid scaling up of production by biopharmaceutical companies tmeet the unprecedented global demand for vaccines. The pandemic underscored the importance of maintaining sterility and minimizing contamination risks in pharmaceutical and biologics production, highlighting the significance of single-use products in such scenarios.
Furthermore, the benefits of using SUT, such as significant cost reduction in capital, decreased time in operation & construction of a facility, and environmental sustainability, have supported the implementation of single-use systems in the bioprocessing market. The current industry trend of perfusion and continuous cell culture in bioprocessing has greatly enabled the use of single-use equipment. Single-use technologies offer enhanced mobility, ease of sampling, higher productivity, and faster product changeovers, further boosting their implementation in the biopharmaceutical industry. The following figure represents the usage of single-use disposables in biopharmaceutical manufacturing.
In addition, membrane adsorbers and columns for downstream chromatography have provided faster product output with decreased processing time and are now the single-use alternative tresins. For instance, drug product-filling operations can be carried out in single-use systems. For instance, in August 2023, Trelleborg Healthcare and Medical launched the BioPharmaPrfamily of advanced products and services for fluid path single-use equipment tboost the development of advanced therapies. Similarly, in February 2021, Cytiva acquired Varnx Pharmasystems, a Canadian aseptic filling innovator, and brought single-use flow paths for drug product filling. Due tthe growth in single-use trends, the single-use workstation for filling and sterile operations will pose a great opportunity for the players in this market.
With the continued demand for biopharmaceuticals, CMOs have adopted these single-use systems for highly dynamic and frequent changes in product portfolios. Some of the major factors for the adoption of this technology by the CMOs are ease of use, flexibility, energy & capital cost reduction features, and decreased turnaround time for product changeover. Due tthe benefits above and process advantages like performance efficiency, SUS has allowed CMOs ttransition between product campaigns quickly. The adoption of SUS has resulted in CMOs building multiproduct facilities and providing enhanced services for faster market penetration of commercial products. For instance, in October 2024, Lonza acquired Roche’s Genentech facility in Vacaville for USD 1.2 billion. This strategic move significantly expanded its large-scale biological manufacturing capacity, catering tthe growing demand for mammalian therapies.
U.S. Single-use Bioprocessing Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 t2030. For this report, Grand View Research has segmented the U.S. Single-use bioprocessing market report based on product, workflow, and end use.
U.S. Single-use Bioprocessing Market Trends
The U.S. single-use bioprocessing market size was estimated at USD 9.34 billion in 2024 and is projected tgrow at a CAGR of 15.04% from 2025 t2030. Due tthe high demand for biopharmaceuticals, suppliers have made their disposable product offerings more robust and inclusive. Single-use equipment suppliers are trying tfulfill end users' growing and ever-changing expectations. Furthermore, significant technological advancements in bioreactor designs, mixing systems, fluid assemblies, and liner technologies are anticipated tdrive the implementation of single-use technology for biopharmaceutical developments & advancements.
The U.S. single-use bioprocessing industry experienced a positive impact from the COVID-19 pandemic, particularly due tthe increased demand for single-use products driven by the heightened need for vaccines, treatments, and assays. These products played an important role in facilitating the rapid scaling up of production by biopharmaceutical companies tmeet the unprecedented global demand for vaccines. The pandemic underscored the importance of maintaining sterility and minimizing contamination risks in pharmaceutical and biologics production, highlighting the significance of single-use products in such scenarios.
Furthermore, the benefits of using SUT, such as significant cost reduction in capital, decreased time in operation & construction of a facility, and environmental sustainability, have supported the implementation of single-use systems in the bioprocessing market. The current industry trend of perfusion and continuous cell culture in bioprocessing has greatly enabled the use of single-use equipment. Single-use technologies offer enhanced mobility, ease of sampling, higher productivity, and faster product changeovers, further boosting their implementation in the biopharmaceutical industry. The following figure represents the usage of single-use disposables in biopharmaceutical manufacturing.
In addition, membrane adsorbers and columns for downstream chromatography have provided faster product output with decreased processing time and are now the single-use alternative tresins. For instance, drug product-filling operations can be carried out in single-use systems. For instance, in August 2023, Trelleborg Healthcare and Medical launched the BioPharmaPrfamily of advanced products and services for fluid path single-use equipment tboost the development of advanced therapies. Similarly, in February 2021, Cytiva acquired Varnx Pharmasystems, a Canadian aseptic filling innovator, and brought single-use flow paths for drug product filling. Due tthe growth in single-use trends, the single-use workstation for filling and sterile operations will pose a great opportunity for the players in this market.
With the continued demand for biopharmaceuticals, CMOs have adopted these single-use systems for highly dynamic and frequent changes in product portfolios. Some of the major factors for the adoption of this technology by the CMOs are ease of use, flexibility, energy & capital cost reduction features, and decreased turnaround time for product changeover. Due tthe benefits above and process advantages like performance efficiency, SUS has allowed CMOs ttransition between product campaigns quickly. The adoption of SUS has resulted in CMOs building multiproduct facilities and providing enhanced services for faster market penetration of commercial products. For instance, in October 2024, Lonza acquired Roche’s Genentech facility in Vacaville for USD 1.2 billion. This strategic move significantly expanded its large-scale biological manufacturing capacity, catering tthe growing demand for mammalian therapies.
U.S. Single-use Bioprocessing Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 t2030. For this report, Grand View Research has segmented the U.S. Single-use bioprocessing market report based on product, workflow, and end use.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Simple & Peripheral Elements
- Tubing, Filters, Connectors, & Transfer Systems
- Bags
- Sampling Systems
- Probes, Sensors, & Flow Meters
- pH Sensor
- Oxygen Sensor
- Pressure Sensors
- Temperature Sensors
- Conductivity Sensors
- Flow Meters & Sensors
- Others
- Others
- Apparatus & Plants
- Bioreactors
- Upt1000L
- Above 1000L t2000L
- Above 2000L
- Mixing, Storage, & Filling Systems
- Filtration System
- Chromatography Systems
- Pumps
- Others
- Work Equipment
- Cell Culture System
- Syringes
- Others
- Workflow Outlook (Revenue, USD Million, 2018 - 2030)
- Upstream
- Fermentation
- Downstream
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical Manufacturer
- CMOs & CROs
- In-house Manufacturer
- Academic & Clinical Research Institutes
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Workflow Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Advantages associated with the implementation of single-use technology in the bio-manufacturing process
3.2.1.2. Increasing investments in the expansion of CGMP manufacturing
3.2.1.3. Widespread adoption of single-use technology by CMOS
3.2.2. Market Restraint Analysis
3.2.2.1. Concerns due to leachables and extractables
3.2.2.2. Limited adoption of single-use technology in downstream process
3.2.3. Market Challenge Analysis
3.2.3.1. Delay in the delivery speed and supply chain of customized products
3.2.3.2. Restraints with scalability of single-use operations
3.2.3.3. Vast availability of multiuse systems
3.2.4. Market Opportunity Analysis
3.2.4.1. Developing technologies for downstream adoption
3.2.4.2. CMO-outsourcing to focus on the new product development
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. U.S. SINGLE-USE BIOPROCESSING MARKET: PRODUCT BUSINESS ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Single-use Bioprocessing Market Product Movement Analysis
4.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Simple & Peripheral Elements
4.4.1. Simple & peripheral elements market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.1. Tubing, Filters, Connectors, & Transfer Systems
4.4.1.1.1. Tubing, filters, connectors, & transfer systems market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.2. Bags
4.4.1.2.1. Bags market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.3. Sampling Systems
4.4.1.3.1. Sampling systems market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4. Probes, Sensors, & Flow Meters
4.4.1.4.1. Probes, sensors, & flow meters market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.2. pH Sensor
4.4.1.4.2.1. pH sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.3. Oxygen Sensor
4.4.1.4.3.1. Oxygen sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.4. Pressure Sensor
4.4.1.4.4.1. Pressure sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.5. Temperature Sensor
4.4.1.4.5.1. Temperature sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.6. Conductivity Sensor
4.4.1.4.6.1. Conductivity sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.7. Flow Meters & Sensor
4.4.1.4.7.1. Flow meters & sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.8. Others
4.4.1.4.8.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.5. Apparatus & Plants
4.5.1. Apparatus & plants market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2. Bioreactors
4.5.2.1. Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.2. Upto 1000L
4.5.2.2.1. Upto 1000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.3. Above 1000L to 2000L
4.5.2.3.1. Above 1000L to 2000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.4. Above 2000L
4.5.2.4.1. Above 2000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3. Mixing, Storage, & Filling Systems
4.5.3.1. Mixing, storage, & filling systems market estimates and forecast, 2018 - 2030 (USD Million)
4.5.4. Filtration System
4.5.4.1. Filtration system market estimates and forecast, 2018 - 2030 (USD Million)
4.5.5. Chromatography Systems
4.5.5.1. Chromatography systems market estimates and forecast, 2018 - 2030 (USD Million)
4.5.6. Pumps
4.5.6.1. Pumps market estimates and forecast, 2018 - 2030 (USD Million)
4.5.7. Others
4.5.7.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.6. Work Equipment
4.6.1. Work Equipment market estimates and forecast, 2018 - 2030 (USD Million)
4.6.2. Cell Culture System
4.6.2.1. Cell Culture System market estimates and forecast, 2018 - 2030 (USD Million)
4.6.3. Syringes
4.6.3.1. Syringes market estimates and forecast, 2018 - 2030 (USD Million)
4.6.4. Others
4.6.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. SINGLE-USE BIOPROCESSING MARKET: WORKFLOW BUSINESS ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Single-use Bioprocessing Market Workflow Movement Analysis
5.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Upstream
5.4.1. Upstream market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Fermentation
5.5.1. Fermentation market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Downstream
5.6.1. Downstream market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. SINGLE-USE BIOPROCESSING MARKET: END USE BUSINESS ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Single-use Bioprocessing Market End Use Movement Analysis
6.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical Manufacturer
6.4.1. Biopharmaceutical manufacturer market estimates and forecast, 2018 - 2030 (USD Million)
6.4.2. CMOs & CROs
6.4.2.1. CMOs & CROs market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. In-house Manufacturer
6.4.3.1. In-house manufacturer market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Academic & Clinical Research Institutes
6.5.1. Academic & clinical research institutes market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Categorization
7.2. Company Market Position Analysis, 2024
7.3. Company Profiles
7.3.1. Sartorius AG
7.3.1.1. Overview
7.3.1.2. Financial performance
7.3.1.3. Product & service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Danaher
7.3.2.1. Overview
7.3.2.2. Financial performance
7.3.2.3. Product & service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Thermo Fisher Scientific, Inc.
7.3.3.1. Overview
7.3.3.2. Financial performance
7.3.3.3. Product & service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Merck KGaA
7.3.4.1. Overview
7.3.4.2. Financial performance
7.3.4.3. Product & service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Avantor, Inc.
7.3.5.1. Overview
7.3.5.2. Financial performance
7.3.5.3. Product & service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Eppendorf SE
7.3.6.1. Overview
7.3.6.2. Financial performance
7.3.6.3. Product & service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Corning Incorporated
7.3.7.1. Overview
7.3.7.2. Financial performance
7.3.7.3. Product & service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Meissner Filtration Products, Inc.
7.3.8.1. Overview
7.3.8.2. Financial performance
7.3.8.3. Product & service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Lonza
7.3.9.1. Overview
7.3.9.2. Financial performance
7.3.9.3. Product & service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. PBS Biotech, Inc.
7.3.10.1. Overview
7.3.10.2. Financial performance
7.3.10.3. Product & service benchmarking
7.3.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Workflow Segment
1.2.3. End Use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Advantages associated with the implementation of single-use technology in the bio-manufacturing process
3.2.1.2. Increasing investments in the expansion of CGMP manufacturing
3.2.1.3. Widespread adoption of single-use technology by CMOS
3.2.2. Market Restraint Analysis
3.2.2.1. Concerns due to leachables and extractables
3.2.2.2. Limited adoption of single-use technology in downstream process
3.2.3. Market Challenge Analysis
3.2.3.1. Delay in the delivery speed and supply chain of customized products
3.2.3.2. Restraints with scalability of single-use operations
3.2.3.3. Vast availability of multiuse systems
3.2.4. Market Opportunity Analysis
3.2.4.1. Developing technologies for downstream adoption
3.2.4.2. CMO-outsourcing to focus on the new product development
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. U.S. SINGLE-USE BIOPROCESSING MARKET: PRODUCT BUSINESS ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Single-use Bioprocessing Market Product Movement Analysis
4.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Simple & Peripheral Elements
4.4.1. Simple & peripheral elements market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.1. Tubing, Filters, Connectors, & Transfer Systems
4.4.1.1.1. Tubing, filters, connectors, & transfer systems market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.2. Bags
4.4.1.2.1. Bags market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.3. Sampling Systems
4.4.1.3.1. Sampling systems market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4. Probes, Sensors, & Flow Meters
4.4.1.4.1. Probes, sensors, & flow meters market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.2. pH Sensor
4.4.1.4.2.1. pH sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.3. Oxygen Sensor
4.4.1.4.3.1. Oxygen sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.4. Pressure Sensor
4.4.1.4.4.1. Pressure sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.5. Temperature Sensor
4.4.1.4.5.1. Temperature sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.6. Conductivity Sensor
4.4.1.4.6.1. Conductivity sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.7. Flow Meters & Sensor
4.4.1.4.7.1. Flow meters & sensor market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.4.8. Others
4.4.1.4.8.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.4.1.5. Others
4.4.1.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.5. Apparatus & Plants
4.5.1. Apparatus & plants market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2. Bioreactors
4.5.2.1. Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.2. Upto 1000L
4.5.2.2.1. Upto 1000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.3. Above 1000L to 2000L
4.5.2.3.1. Above 1000L to 2000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2.4. Above 2000L
4.5.2.4.1. Above 2000L market estimates and forecast, 2018 - 2030 (USD Million)
4.5.3. Mixing, Storage, & Filling Systems
4.5.3.1. Mixing, storage, & filling systems market estimates and forecast, 2018 - 2030 (USD Million)
4.5.4. Filtration System
4.5.4.1. Filtration system market estimates and forecast, 2018 - 2030 (USD Million)
4.5.5. Chromatography Systems
4.5.5.1. Chromatography systems market estimates and forecast, 2018 - 2030 (USD Million)
4.5.6. Pumps
4.5.6.1. Pumps market estimates and forecast, 2018 - 2030 (USD Million)
4.5.7. Others
4.5.7.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
4.6. Work Equipment
4.6.1. Work Equipment market estimates and forecast, 2018 - 2030 (USD Million)
4.6.2. Cell Culture System
4.6.2.1. Cell Culture System market estimates and forecast, 2018 - 2030 (USD Million)
4.6.3. Syringes
4.6.3.1. Syringes market estimates and forecast, 2018 - 2030 (USD Million)
4.6.4. Others
4.6.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. SINGLE-USE BIOPROCESSING MARKET: WORKFLOW BUSINESS ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Single-use Bioprocessing Market Workflow Movement Analysis
5.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Upstream
5.4.1. Upstream market estimates and forecast, 2018 - 2030 (USD Million)
5.5. Fermentation
5.5.1. Fermentation market estimates and forecast, 2018 - 2030 (USD Million)
5.6. Downstream
5.6.1. Downstream market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. SINGLE-USE BIOPROCESSING MARKET: END USE BUSINESS ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Single-use Bioprocessing Market End Use Movement Analysis
6.3. U.S. Single-use Bioprocessing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical Manufacturer
6.4.1. Biopharmaceutical manufacturer market estimates and forecast, 2018 - 2030 (USD Million)
6.4.2. CMOs & CROs
6.4.2.1. CMOs & CROs market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. In-house Manufacturer
6.4.3.1. In-house manufacturer market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Academic & Clinical Research Institutes
6.5.1. Academic & clinical research institutes market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Participant Categorization
7.2. Company Market Position Analysis, 2024
7.3. Company Profiles
7.3.1. Sartorius AG
7.3.1.1. Overview
7.3.1.2. Financial performance
7.3.1.3. Product & service benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Danaher
7.3.2.1. Overview
7.3.2.2. Financial performance
7.3.2.3. Product & service benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Thermo Fisher Scientific, Inc.
7.3.3.1. Overview
7.3.3.2. Financial performance
7.3.3.3. Product & service benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Merck KGaA
7.3.4.1. Overview
7.3.4.2. Financial performance
7.3.4.3. Product & service benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Avantor, Inc.
7.3.5.1. Overview
7.3.5.2. Financial performance
7.3.5.3. Product & service benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Eppendorf SE
7.3.6.1. Overview
7.3.6.2. Financial performance
7.3.6.3. Product & service benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Corning Incorporated
7.3.7.1. Overview
7.3.7.2. Financial performance
7.3.7.3. Product & service benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Meissner Filtration Products, Inc.
7.3.8.1. Overview
7.3.8.2. Financial performance
7.3.8.3. Product & service benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Lonza
7.3.9.1. Overview
7.3.9.2. Financial performance
7.3.9.3. Product & service benchmarking
7.3.9.4. Strategic initiatives
7.3.10. PBS Biotech, Inc.
7.3.10.1. Overview
7.3.10.2. Financial performance
7.3.10.3. Product & service benchmarking
7.3.10.4. Strategic initiatives
